Product Details

Veloxa XL Chewable Tablets for Dogs

• MA holder: Lavet Pharmaceuticals Ltd
• VM number: 32823/4011
• Territory: Great Britain
• Aligned product: View aligned product details
• Associated documents:
  • View Summary of Product Characteristics
  • View Product Literature (labelling and package leaflet text)
  • View Post Authorisation Assessment
• Date of issue: 16/01/2013
• Authorisation route: National
• Active substances:
  • Febantel
  • Praziquantel
  • Pyrantel
• Controlled drug: No
• Target species:
  • Dogs
• Distribution category: NFA-VPS
• Distributors:
  • Boehringer Ingelheim Animal Health UK Limited